|

CEA-targeted CAR-T (Intravenous) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.